Rankings
▼
Calendar
LIVN Q2 2017 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q2 2017 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$321M
+0.1% YoY
Gross Profit
$211M
65.6% margin
Operating Income
$31M
9.7% margin
Net Income
$47M
14.8% margin
EPS (Diluted)
$0.98
QoQ Revenue Growth
+12.7%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$9M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$2.5B
Total Liabilities
$690M
Stockholders' Equity
$1.8B
Cash & Equivalents
$43M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$321M
$321M
+0.1%
Gross Profit
$211M
$190M
+10.8%
Operating Income
$31M
$22M
+41.3%
Net Income
$47M
$9M
+430.3%
Revenue Segments
Cardiac Surgery
$159M
49%
Neuromodulation
$97M
30%
Cardiac Rhythm Management
$66M
20%
Geographic Segments
UNITED STATES
$130M
36%
Europe
$105M
30%
Non-U.S. and Europe
$87M
24%
FRANCE
$34M
10%
← FY 2017
All Quarters
Q3 2017 →